| 1 |
33174139 | Memantine, NMDA Receptor Antagonist, Attenuates ox-LDL-Induced Inflammation and Oxidative Stress via Activation of BDNF/TrkB Signaling Pathway in HUVECs. | 2021 Apr |
1 |
| 2 |
29656414 | Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study. | 2018 Jun |
3 |
| 3 |
29695962 | Inhibition of NMDA Receptors Prevents the Loss of BDNF Function Induced by Amyloid β. | 2018 |
1 |
| 4 |
30344474 | Corrigendum: Prenatal Deltamethrin Exposure-Induced Cognitive Impairment in Offspring Is Ameliorated by Memantine Through NMDAR/BDNF Signaling in Hippocampus. | 2018 |
1 |
| 5 |
30984874 | Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity. | 2018 |
1 |
| 6 |
26660109 | Inhibitory Effect of Memantine on Streptozotocin-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Neurotrophic Factor Decline in Astrocytes. | 2016 Dec |
1 |
| 7 |
24103632 | Genotype variant associated with add-on memantine in bipolar II disorder. | 2014 Feb |
2 |
| 8 |
19521778 | An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. | 2009 Jul |
2 |